LORTAB ELIXIR CII
Generic Name and Formulations:
Hydrocodone bitartrate 10mg, acetaminophen 300mg; per 15mL; tropical fruit punch flavor; contains alcohol 7%.
Indications for LORTAB ELIXIR:
Moderate to moderately severe pain.
11.25mL every 4–6hrs as needed; max 67.5mL/day.
<2yrs: not recommended. Give every 4–6hrs as needed; max 6 doses/day. 2–3yrs (12–15kg): 2.8mL; max: 16.8mL/day. 4–6yrs (16–22kg): 3.75mL; max: 22.5mL/day. 7–9yrs (23–31kg): 5.6mL; max: 33.6mL/day. 10–13yrs (32–45kg): 7.5mL; max: 45mL/day. ≥14yrs (≥46kg): 11.25mL; max: 67.5mL.
Head injury. Increased intracranial pressure. Acute abdomen. Impaired renal, hepatic, thyroid, pulmonary, or adrenocortical function. GI or GU obstruction. Asthma. Drug abusers. Elderly. Debilitated. Labor & delivery. Pregnancy (Cat.C). Nursing mothers: not recommended.
Opioid + analgesic.
Potentiation with alcohol, CNS depressants, MAOIs, tricyclic antidepressants, anticholinergics.
Dizziness, CNS depression, respiratory depression, GI upset, constipation, urinary retention; hepatotoxicity (overdosage).
Neurology Advisor Articles
- Rasagiline Plus Riluzole is Safe, May Improve Survival in ALS
- Treatment of New-Onset Epilepsy: AAN, AES Update Practice Guidelines
- Gender Differences in the Epidemiology of Migraine
- Changes in Glucose Regulation in Parkinson Disease
- Apomorphine Infusions Improves Off Time Associated With Parkinson Disease
- Some Statins May Be Associated With Cognition, Memory Deficits
- Neuropathic Pain Treatments
- Cannabis for Multiple Sclerosis: Prescriber's Perspective
- New Monoclonal Antibody BAN2401 Reduces Amyloid Plaques, Improves Cognition in Alzheimer's
- Nonpharmacologic Interventions for Alzheimer's Have Greater Impact on Outcomes Than Currently Available Medications
- Locally Asymptomatic Ischemic Stroke May Present as Migraine Aura
- Associations Identified Between Stroke Severity, Recovery of Visuospatial Neglect
- Action Tremor May Have Central Origin in Motor Neuron Disease
- Characteristics Affecting Health-Related Quality of Life in RRMS, Progressive MS
- Neurodevelopmental Anomalies, Birth Defects Linked to Zika ID'd